Home
About Us
Pharma-Free CME
Resources by Topic
Resources by Type
Teaching Tools
Drug Industry
Contact Us
How You Can Help
RSS NEWS FEED 
PharmedOut Publications and Other Materials
Articles
Do New Drugs Increase Life Expectancy?
Journal of General Internal Medicine
A critique of a Manhattan Institute paper
Ethical Considerations of Publication Planning in the Pharmaceutical Industry
Open Medicine
How industry uses medical writers to manipulate the medical literature
Off-Label Promotion, On-Target Sales
Public Library of Science
The covert promotion of drugs for unapproved uses
Thus Are Our Medical Meetings Managed (also read letter here)
British Medical Journal
Key opinion leaders may be unaware of pharma influence
Prescription Tracking and Public Health
Journal of General Internal Medicine
Why the AMA's opt-out plan does not protect prescribing privacy
Following the Script: How Drug Reps Make Friends and Influence Doctors
Public Library of Science
Psychological techniques reps use to sell drugs
Doctors Must Not be Lapdogs to Drug Firms
British Medical Journal
Drug reps stomp out of a talk about industry influence
“This May Sting a Bit”: Cutting CME’s Ties to Pharma
Virtual Mentor
CME should go pharma-free
PLoS Medicine
Taking ads for luxury goods would be less compromising to medical journals than accepting only drug ads
Gynecologists and Estrogen: An Affair of the Heart
Perspectives in Biology and Medicine
Ob-gyns believe in HT despite evidence
Other Materials
Letter to NIH: fund ethics research (pdf)
PharmedOut 2009 Annual Report (pdf)
No Drug Reps Certificate (pdf)
Unbiased Resources (doc)
How to Hold Pharma-free Meetings (pdf)
Prescription Drug Marketing: What Consumers Need to Know (pdf)
Fast Facts on Generics (pdf)
Drug Approval in the US: How Drugs get to Market (CME)
Generic Drugs: Prescribing Sensibly (CME)
The Physician-Pharma Relationship (powerpoint)
Bring Your Own Lunch (BYOL) Sandwich Guide (pdf)
Other Publications
Mammography and the Corporate Breast
Bioethics Forum
Ghostwritten Articles Helped Sell Hormones
Women's Health Activist
Bone-Breaking Drugs?
Women's Health Activist
Deceptive Market Practices in the Marketplace of Ideas
Bioethics Forum
Help Your Doctor Break the Sample Habit
Women's Health Activist
Smoke and Mirrors
Bioethics Forum
Hormones for Hot Flashes - Is "Natural" Better?
Women's Health Activist
Meds in Kids
Women's Health Activist
Women's Health Activist
Classic Drugs Under Attack
Bioethics Forum
Women’s Health Activist
Cervical Cancer Vaccines and Industry Influence
Bioethics Forum
The Waiting Room: Pharma's Latest Lair
Bioethics Forum
The Dog Ate My Disclosure
Bioethics Forum
Hold the Hype on HPV
Women's Health Activist
Over-the-Counter Sales of Medical Records
Women's Health Activist
Cervical Cancer Vaccines in Context
Women's Health Activist
Less Hormone Therapy, Less Breast Cancer
Women's Health Activist
Big Pharma Wants to Know All About You
Women's Health Activist
A Bone to Pick with Bone Drugs
Women's Health Activist
Waiting Room Activism
Women's Health Activist
Why Race-Based Medicine is a Bad Idea
Women's Health Activist
Just Say No to New Drugs
Women's Health Activist
Our Videos
Pharma Insider II
Opposition research
(read transcript)
Pharma Insider I
Off-label promotion under the radar
(read transcript)
The Art of Medical Writing
Pharma's anonymous writers
Drug Reps Talk Shop II
Drug reps continue their chat
Drug Reps Talk Shop I Selling drugs to docs
Director of PharmedOut Explains the Project
Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug
News
Drug Firms Turn to Private Docs to Promote Products
University ethics policies tightened Milwaukee Journal Sentinel
J&J Pushed Risperdal After Warning, Files Show
FDA ignored; CME supported off-label uses Bloomberg
NIH Should Disclose Financial Conflicts
Public database requested Pharmalot
Diabetes Heart Treatments May Cause Harm
Normalizing BP and postprandial hyperglycemia don't help NYT
Grassley Tells PBMs To Disclose Ties To Pharma
Drugmakers may provide financial benefits Pharmalot
Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ
States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune
Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle
Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal
Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT
Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT
Commentary
Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum
Click HERE to read the entire news archives
Department of Physiology and Biophysics * Box 571460 * Washington, DC 20057-1460